PNU-103017

• Description :

  PNU-103017 is an HIV protease inhibitor.

• UNSPSC :

  12352005

• Target :

  HIV; HIV Protease

• Type :

  Reference compound

• Related Pathways :

  Anti-infection; Metabolic Enzyme/Protease

• Applications :

  COVID-19-anti-virus

• Field of Research :

  Infection

• Assay Protocol :

  https://www.medchemexpress.com/PNU-103017.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O=S(C1=CC=C(C#N)C=C1)(NC2=CC=CC(C(C3CC3)C4=C(O)C(CCCCCC5)=C5OC4=O)=C2)=O

• Molecular Formula :

  C28H28N2O5S

• Molecular Weight :

  504.60

• References & Citations :

  [1]Williams MG, et al. Stereospecific determination of an HIV aspartyl protease inhibitor, PNU-103017, in rat, dog and human plasma using a Pirkle-concept high-performance liquid chromatographic column.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  Phase 1

• CAS Number :

  [166335-18-8]